Literature DB >> 18832689

Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion.

Ruan Zhang1, Na Zhang, Daniel L Mueller.   

Abstract

Optimal clonal expansion of CD4(+) T cells during the primary response to Ag requires prolonged TCR recognition of peptide Ag/MHC complexes. In this study, we investigated the capacity of Casitas B-lineage lymphoma b (Cbl-b) to counter-regulate late TCR signals necessary for continued cell division in vivo. During the first 24 h of a primary response to Ag, Cblb(-/-) 5C.C7 CD4(+) T cells demonstrated no alteration in CD69, CD25, and CD71 up-regulation or cell growth as compared with wild-type cells. Nevertheless, beyond 24 h, both the expression of CD71 and the rate of cell division were increased in the genetic absence of Cbl-b, leading to an augmented clonal expansion. This deregulation of late T cell proliferation in the absence of Cbl-b resulted in part from an inability of Cblb(-/-) T cells to desensitize Akt, PLCgamma-1, and ERK phosphorylation events downstream of the TCR/CD3 complex, in addition to their failure to undergo a growth arrest in the absence of Ag. These observations now suggest a novel role for Cbl-b in triggering the exit from cell cycle at the end of a CD4(+) T cell clonal expansion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832689      PMCID: PMC2597533          DOI: 10.4049/jimmunol.181.8.5331

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G1-->S phase transitions at an optimal rate.

Authors:  Jody L Bonnevier; Cory A Yarke; Daniel L Mueller
Journal:  Eur J Immunol       Date:  2006-06       Impact factor: 5.532

2.  Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.

Authors:  Mohammed Shamim; Som G Nanjappa; Anju Singh; Erin Hemmila Plisch; Scott E LeBlanc; Jane Walent; John Svaren; Christine Seroogy; M Suresh
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

3.  Proliferating CD4+ T cells undergo immediate growth arrest upon cessation of TCR signaling in vivo.

Authors:  Cory A Yarke; Stacy L Dalheimer; Na Zhang; Drew M Catron; Marc K Jenkins; Daniel L Mueller
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

4.  Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion.

Authors:  Zacarias Garcia; Emmanuelle Pradelli; Susanna Celli; Hélène Beuneu; Aurélie Simon; Philippe Bousso
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

5.  Real-time manipulation of T cell-dendritic cell interactions in vivo reveals the importance of prolonged contacts for CD4+ T cell activation.

Authors:  Susanna Celli; Fabrice Lemaître; Philippe Bousso
Journal:  Immunity       Date:  2007-10-18       Impact factor: 31.745

6.  Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.

Authors:  Reinhard Obst; Hisse-Martien van Santen; Rachel Melamed; Alice O Kamphorst; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

7.  Naive and memory CD4+ T cell survival controlled by clonal abundance.

Authors:  Jason Hataye; James J Moon; Alexander Khoruts; Cavan Reilly; Marc K Jenkins
Journal:  Science       Date:  2006-03-02       Impact factor: 47.728

8.  A role for mammalian target of rapamycin in regulating T cell activation versus anergy.

Authors:  Yan Zheng; Samuel L Collins; Michael A Lutz; Amy N Allen; Thomas P Kole; Paul E Zarek; Jonathan D Powell
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

9.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

10.  T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.

Authors:  Guilin Qiao; Zhenping Li; Luciana Molinero; Maria-Luisa Alegre; Haiyan Ying; Zuoming Sun; Josef M Penninger; Jian Zhang
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

View more
  9 in total

1.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.

Authors:  Ingunn M Stromnes; Joseph N Blattman; Xiaoxia Tan; Sara Jeevanjee; Hua Gu; Philip D Greenberg
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.

Authors:  Xiujuan Qu; Yingchun Li; Jing Liu; Ling Xu; Ye Zhang; Xuejun Hu; Kezuo Hou; Yunpeng Liu
Journal:  Mol Cell Biochem       Date:  2010-02-24       Impact factor: 3.396

3.  Cbl-b regulates airway mucosal tolerance to aeroallergen.

Authors:  S Y Oh; J-U Park; T Zheng; Y-K Kim; F Wu; S H Cho; D Barber; J Penninger; Z Zhu
Journal:  Clin Exp Allergy       Date:  2010-08-25       Impact factor: 5.018

4.  The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.

Authors:  Marie-Clare St Rose; Harry Z Qui; Suman Bandyopadhyay; Marianne A Mihalyo; Adam T Hagymasi; Robert B Clark; Adam J Adler
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

5.  Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.

Authors:  Jack T Lin; Neil B Lineberry; Michael G Kattah; Leon L Su; Paul J Utz; C Garrison Fathman; Linda Wu
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

6.  Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Authors:  Petrus Jansen van Vuren; Caroline T Tiemessen; Janusz T Paweska
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

7.  Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells.

Authors:  Dan Feng; Yanju Ma; Jing Liu; Ling Xu; Ye Zhang; Jinglei Qu; Yunpeng Liu; Xiujuan Qu
Journal:  Int J Mol Sci       Date:  2013-12-16       Impact factor: 5.923

8.  Cbl-b deficiency prevents functional but not phenotypic T cell anergy.

Authors:  Trang T T Nguyen; Zhi-En Wang; Lin Shen; Andrew Schroeder; Walter Eckalbar; Arthur Weiss
Journal:  J Exp Med       Date:  2021-05-11       Impact factor: 14.307

9.  OX40-Fc Fusion Protein Alleviates PD-1-Fc-Aggravated Rheumatoid Arthritis by Inhibiting Inflammatory Response.

Authors:  Yanyan Huang; Shudian Lin; Feng Zhan; Lu Xiao; Yuwei Zhan; Ru Wang
Journal:  Comput Math Methods Med       Date:  2022-02-17       Impact factor: 2.238

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.